Clinical Trials Unit

Improved protection against infectious diseases through vaccination has been an important topic at our institute for many years. Together with renowned vaccine developers, we have been researching and working on new developments and improvements to vaccines for over 25 years. Another focus is the research and discovery of new diagnostics.

We are dependent on your support in order to be able to carry out studies. If you are interested, we look forward to hearing from you and will be happy to provide you with further information.

Since March 27, 2025, the Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich has been accredited by the French Ministry of Higher Education and Research as an innovative research service provider eligible under the Crédit d’Impôt Recherche (CIR) program. This accreditation allows French sponsors to claim tax benefits for research services provided by us in the field of early-phase clinical trials.

The accreditation is valid for the years 2025, 2026, 2027, 2028, and 2029.